Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 268

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings

Open access
Acestor, Nathalie, Goett, Jane, Lee, Arthur, Herrick, Tara M., Engelbrecht, Susheela M., Harner-Jay, Claudia M., Howell, Bonnie J., Weigl, Bernhard H.·2016·Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract

In recent years, an increasing amount of literature is emerging on candidate urine and blood-based biomarkers associated with incidence and severity of preeclampsia (PE) in pregnant women. While enthusiasm on the usefulness of several of these markers in predicting PE is evolving, essentially all work so far has focused on the needs of high-resource settings and high-income countries, resulting primarily in multi-parameter laboratory assays based on proteomic and metabolomics analysis techniques. These highly complex methods, however, require laboratory capabilities that are rarely available or affordable in low-resource settings (LRS). The importance of quantifying maternal and perinatal risks and identifying which pregnancies can be safely prolonged is also much greater in LRS, where intensive care facilities that can rapidly respond to PE-related health threats for women and infants are limited. For these reasons, simple, low cost, sensitive, and specific point-of-care (POC) tests are needed that can be performed by antenatal health care providers in LRS and that can facilitate decisions about detection and management of PE. Our study aims to provide a comprehensive systematic review of current and emerging blood and urine biomarkers for PE, not only on the basis of their clinical performance, but also of their suitability to be used in LRS-compatible test formats, such as lateral flow and other variants of POC rapid assays.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/cclm-2015-0069

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Metadata

Authors
Acestor, N., Goett, J., Lee, A., Herrick, T. M., Engelbrecht, S. M., Harner-Jay, C. M., Howell, B. J., & Weigl, B. H.
Venue
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2016-01-01
Volume
54
Issue
1
Pages
17-27
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W1590110164
Cited by
268
References
56
FWCI
2.59
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings. https://app.cochat.ai/papers/10.1515/cclm-2015-0069
The paper
Acestor, N., Goett, J., Lee, A., Herrick, T. M., Engelbrecht, S. M., Harner-Jay, C. M., Howell, B. J., & Weigl, B. H. (2016). Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2015-0069

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.